SGMT Sagimet Biosciences Inc.
Healthcare$7.21+0.00%OpenMarket Cap: $234.8M
As of 2026-05-26
Insider Statistics (Q1 2026)
Acquisitions
8
Dispositions
4
Buy/Sell Ratio
2.00
Net Shares
+760,325
Shares Acquired
780,000
Shares Disposed
19,675
Total Bought ($)
$0.00
Total Sold ($)
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu May 14 | Grauer Andreas | officer: Chief Medical Officer | Sell | 264,759 | $6.44 | 264,759 |
| Thu May 14 | Grauer Andreas | officer | Sell | 0 | $0.00 | 0 |
| Fri Feb 20 | Rozek Elizabeth | officer: Chief Legal & Admin. Officer | Sell | 88,000 | $5.38 | 88,000 |
| Fri Feb 20 | Rozek Elizabeth | officer: Chief Legal & Admin. Officer | Sell | 44,000 | $0.00 | 234,959 |
| Fri Feb 20 | Martins Eduardo Bruno | officer: Chief Medical Officer | Sell | 88,000 | $5.38 | 88,000 |
| Fri Feb 20 | Martins Eduardo Bruno | officer: Chief Medical Officer | Sell | 44,000 | $0.00 | 147,296 |
| Fri Feb 20 | Happel David | director, officer: President & CEO | Sell | 256,000 | $5.38 | 256,000 |
| Fri Feb 20 | Happel David | director, officer: President & CEO | Sell | 128,000 | $0.00 | 805,621 |
| Fri Feb 20 | Chauche Thierry | officer: Chief Financial Officer | Sell | 88,000 | $5.38 | 88,000 |
| Fri Feb 20 | Chauche Thierry | officer: Chief Financial Officer | Sell | 44,000 | $0.00 | 59,688 |
| Thu Feb 12 | Happel David | director, officer: President & CEO | Sell | 12,101 | $5.36 | 677,621 |
| Thu Feb 12 | Chauche Thierry | officer: Chief Financial Officer | Sell | 1,312 | $5.36 | 15,688 |